美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Repros Therapeutics Inc. - Series A Warrant

1.17

+0.220023.16%

成交量：700.00

成交額：819.00

市值：- -

市盈率：-1.98

高：1.24

開：1.23

低：1.17

收：0.9500

52周最高：1.24

52周最低：1.17

股本：- -

流通股本：- -

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.5900

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Repros Therapeutics Inc. - Series A Warrant

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Repos Therapeutics is a biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders. Co.'s lead product candidate is Progenta? While second product candidate is Androxal?

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/RPRXW/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RPRXW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RPRXW\",,,,,undefined,":{"symbol":"RPRXW","market":"US","secType":"STK","nameCN":"Repros Therapeutics Inc. - Series A Warrant","latestPrice":1.17,"timestamp":1454533200000,"preClose":0.95,"halted":0,"volume":700,"delay":0,"changeRate":0.23157894736842102,"floatShares":0,"shares":0,"eps":-0.59,"marketStatus":"未開盤","change":0.22,"latestTime":"02-03 16:00:00 EST","open":1.23,"high":1.24,"low":1.17,"amount":819,"amplitude":0.073684,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.59,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1777449600000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":0.95,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RPRXW\",,,,,undefined,":{"symbol":"RPRXW","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":1.24,"amplitude":0.073684,"preClose":0.95,"low":1.17,"week52Low":1.17,"pbRate":"--","week52High":1.24,"institutionHeld":0,"latestPrice":1.17,"eps":-0.59,"divideRate":0,"volume":700,"delay":0,"ttmEps":-0.59,"open":1.23,"prevYearClose":1.17,"prevWeekClose":1.17,"prevMonthClose":1.17,"prevQuarterClose":1.17,"fiveDayClose":1.17,"twentyDayClose":1.17,"sixtyDayClose":1.17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RPRXW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RPRXW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RPRXW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://","compareEarnings":[{"period":"1week","weight":0.0091},{"period":"1month","weight":0.1279},{"period":"3month","weight":0.0283},{"period":"6month","weight":0.0404},{"period":"1year","weight":0.2988},{"period":"ytd","weight":0.0488}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Repos Therapeutics is a biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders. Co.'s lead product candidate is Progenta? While second product candidate is Androxal?","exchange":"NASDAQ","name":"Repros Therapeutics Inc. - Series A Warrant","nameEN":"RPRXW"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"RPRXW\",market:\"US\",,,undefined,":null}}